Skip to content

Clinical trials

Major Depressive Disorder trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Not applicable Country / region: China Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20122
20132
20141
20151
20161
20173
20182
20196
20207
20217
202211
202311
202412
20257
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status43
Completed19
Recruiting15
Not yet recruiting9
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center12
Changping Laboratory9
Guangzhou Psychiatric Hospital5
Central South University4
First Affiliated Hospital of Zhejiang University4
Ruijin Hospital4
The Third Affiliated hospital of Zhejiang Chinese Medical University4
Hunan Normal University3
Peking University Sixth Hospital3
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder89
Depressive Disorder, Treatment-Resistant9
Bipolar Disorder5
Depressive Disorder4
Cognitive Dysfunction3
Schizophrenia3
Anhedonia2
Arthritis, Rheumatoid1
Asthma1
Cognition Disorders1

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.